USANA Health Sciences, Inc. (NYSE:USNA - Get Free Report) Director Gilbert A. Fuller sold 675 shares of USANA Health Sciences stock in a transaction dated Monday, November 4th. The stock was sold at an average price of $37.71, for a total value of $25,454.25. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.
Gilbert A. Fuller also recently made the following trade(s):
- On Wednesday, August 7th, Gilbert A. Fuller sold 674 shares of USANA Health Sciences stock. The stock was sold at an average price of $39.69, for a total transaction of $26,751.06.
USANA Health Sciences Stock Up 2.9 %
NYSE USNA opened at $39.03 on Wednesday. The company has a 50-day moving average price of $37.53 and a 200-day moving average price of $42.08. USANA Health Sciences, Inc. has a 52 week low of $34.15 and a 52 week high of $54.81. The firm has a market capitalization of $743.43 million, a P/E ratio of 13.79, a PEG ratio of 1.29 and a beta of 0.89.
USANA Health Sciences (NYSE:USNA - Get Free Report) last announced its earnings results on Tuesday, October 22nd. The company reported $0.56 EPS for the quarter, beating analysts' consensus estimates of $0.49 by $0.07. The business had revenue of $200.22 million during the quarter, compared to analysts' expectations of $208.45 million. USANA Health Sciences had a net margin of 6.30% and a return on equity of 10.64%. During the same period in the prior year, the company earned $0.59 earnings per share. As a group, equities research analysts anticipate that USANA Health Sciences, Inc. will post 2.45 EPS for the current year.
Analyst Upgrades and Downgrades
We recommended Nvidia in 2016, now we’re recommending this…
From Porter & Company | Ad
The AI boom is just getting started.
And the real wealth has still to be made…
You must read this new presentation from Porter Stansberry.
Several equities research analysts recently issued reports on the stock. DA Davidson dropped their target price on shares of USANA Health Sciences from $38.00 to $35.00 and set a "neutral" rating on the stock in a report on Wednesday, October 23rd. StockNews.com downgraded USANA Health Sciences from a "strong-buy" rating to a "buy" rating in a research note on Wednesday, July 24th.
View Our Latest Research Report on USNA
Institutional Trading of USANA Health Sciences
Several hedge funds have recently bought and sold shares of USNA. BOKF NA raised its stake in shares of USANA Health Sciences by 274.5% in the first quarter. BOKF NA now owns 2,771 shares of the company's stock worth $133,000 after buying an additional 2,031 shares during the period. Price T Rowe Associates Inc. MD raised its stake in USANA Health Sciences by 9.2% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 5,849 shares of the company's stock worth $284,000 after acquiring an additional 494 shares during the period. SG Americas Securities LLC purchased a new position in USANA Health Sciences during the second quarter valued at approximately $340,000. Exchange Traded Concepts LLC lifted its holdings in USANA Health Sciences by 4.4% during the third quarter. Exchange Traded Concepts LLC now owns 7,709 shares of the company's stock valued at $292,000 after purchasing an additional 322 shares in the last quarter. Finally, State Board of Administration of Florida Retirement System boosted its position in shares of USANA Health Sciences by 22.7% in the first quarter. State Board of Administration of Florida Retirement System now owns 8,430 shares of the company's stock worth $409,000 after purchasing an additional 1,560 shares during the period. Institutional investors own 54.25% of the company's stock.
USANA Health Sciences Company Profile
(
Get Free Report)
USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
